IssuerAnnouncementDetailsV2Portlet

Actions

Dr. Soliman Abdel Kader Fakeeh Hospital Co. announces its Interim Financial results for the Period Ending on 2026-03-31 ( Three Months )

4017
FAKEEH CARE
0.33 %
1447/11/19     06/05/2026 08:41:22

Element ListCurrent QuarterSimilar quarter for previous year%ChangePrevious Quarter% Change
Sales/Revenue 724.15701.023.299799.12-9.381
Gross Profit (Loss) 139.9176.14-20.574169.89-17.652
Operational Profit (Loss) 44.6176.98-42.04975.28-40.741
Net Profit (Loss) Attributable to Shareholders of the Issuer 38.4172.2-46.864.22-40.189
Total Comprehensive Income Attributable to Shareholders of the Issuer 38.4172.2-46.856.62-32.161
All figures are in (Millions) Saudi Arabia, Riyals


Element ListCurrent PeriodSimilar period for previous year%Change
Total Shareholders Equity (after Deducting Minority Equity) 3,211.623,172.031.248
Profit (Loss) per Share 0.170.31
All figures are in (Millions) Saudi Arabia, Riyals


Element ListAmountPercentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value --
All figures are in (Millions) Saudi Arabia, Riyals


Element ListExplanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is The Group served 1% more outpatients, 11% more inpatients, and conducted 17% more surgical procedures in 1Q26 compared with 1Q25, supporting continued growth in higher-acuity activity. In addition, the Group’s New Business revenue, comprising DSFH Riyadh and DSFH Madinah, grew strongly by 78% year on year, supported by the deepening of DSFH Riyadh’s service-line offering and the full-quarter contribution of DSFH Madinah, which had not commenced operations in the comparable period of the previous year. This growth more than offset the impact of the more prolonged Ramadan and Eid Al Fitr seasonality in 1Q26 compared with 1Q25.
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is Despite the increased number of patients served and the growth in New Business, the decrease in Net Profit was mainly due to the more prolonged Ramadan and Eid Al Fitr seasonality in 1Q26 compared with 1Q25, which reduced the effective number of operating days during the quarter and resulted in the Group’s fixed cost base being absorbed across a reduced revenue base.

Profitability was also impacted by ramp-up costs at DSFH Madinah, including front-loaded staffing and depreciation, which were not present in the comparable period in 1Q25.

The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is The decrease in revenue compared with 4Q25 was mainly attributable to the Ramadan and Eid Al Fitr seasonal calendar in 1Q26, which had no equivalent impact in the previous quarter. This reduced the effective number of operating days and affected patients served during the quarter.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is Despite a SAR 45 million decrease in the Group’s aggregate COGS and SG&A in 1Q26 compared with 4Q25, revenue was SAR 75 million lower quarter on quarter, mainly due to the Ramadan and Eid Al Fitr seasonal calendar in 1Q26, which had no equivalent impact in the previous quarter. While costs were lower, the reduced effective number of operating days lowered patients served and revenue, reducing the absorption of the Group’s cost in 1Q26.
Statement of the type of external auditor's report Unmodified conclusion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) NA
Reclassification of Comparison Items NA
Additional Information NA
Attached Documents  

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Performance

FAKEEH CARE
Add To Watchlist
In your Watchlist
Add To Watchlist
Key Parameters
Last Price 36.66
Net Change 0.12 (+0.33%)
Value Traded (Sar) 1,825,633.88
Volume Traded 49,652
See The Company Profile

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions
NO PORTLET SESSION YET